Search Results (1 to 4 of 4 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 1 JMIR Formative Research
- 1 JMIR Human Factors
- 1 JMIR Mental Health
- 1 JMIR mHealth and uHealth
- 0 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Research Protocols
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR Serious Games
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
In this study, our aim was to evaluate the effects of the m-RESIST solution on the clinical and functional outcomes and the perceived quality of life for those with TRS. To our best knowledge, there are no previous studies which have addressed these issues.
This was a prospective, 3-month long, multicenter follow-up study without a control group that was carried out with patients with a diagnosis of TRS between March and November 2017. Blinding was not considered due to the absence of a comparator group.
JMIR Hum Factors 2025;12:e67659
Download Citation: END BibTex RIS
We hypothesized that the m-RESIST intervention would have acceptable rates of willingness to enroll (≥70%) and attrition (nonusage and dropout attrition
A prospective multicenter feasibility study without a control group was performed in patients with a diagnosis of TRS between March and November 2017.
JMIR Form Res 2023;7:e46179
Download Citation: END BibTex RIS
In this context, the Mobile Therapeutic Attention for Patients with Treatment-Resistant Schizophrenia (m-RESIST) project [22] addresses patients with TRS by allowing caregivers and professionals to utilize mobile technology as part of the care process.
JMIR Ment Health 2019;6(2):e9819
Download Citation: END BibTex RIS
With the intention of improving the quality of care of outpatients with treatment-resistant schizophrenia, an m Health solution termed Mobile Therapeutic Attention for Patients with Treatment-Resistant Schizophrenia (m-RESIST) is being designed in the European Union.
JMIR Mhealth Uhealth 2016;4(3):e112
Download Citation: END BibTex RIS